Regenerative medicine in society: Interdisciplinary perspectives

November 13, 2017

Future Science Group (FSG) is excited to announce the release of a two-part Special Focus Issue of Regenerative Medicine entitled "Regenerative Medicine in Society: Interdisciplinary Perspectives". This expansive collection offers perspectives on key social, ethical, policy and regulatory issues across many areas of the rapidly evolving field of regenerative medicine.

The Special Focus Issue has been guest edited by Achim Rosemann (University of Warwick, UK), Jan Barfoot and Clare Blackburn (both MRC Centre for Regenerative Medicine, University of Edinburgh, UK).

"This double special issue brings together almost 30 articles from leading interdisciplinary researchers on regenerative medicine innovation," stated Rosemann. "It provides up-to-date insights into recent regulatory developments, challenges to international harmonization, new perspectives on cell and tissue banking as well as critical reflections on the marketing of stem cell therapies, among many other themes."

Through the involvement of Barfoot and Blackburn, the European Commission-funded EuroStemCell project, which aims to educate the public on stem cells and their impact on society, has collaborated with Regenerative Medicine toward the publication of these issues.

"Regenerative medicine is firmly part of our society and so the opportunity to gain cross-disciplinary insights from the range of globally-recognized scholars in this Special Focus Issue is timely and welcome," explained Barfoot.

"It is vital that it is not only academics but society as a whole who participates in the conversations surrounding regenerative medicine and stem cell research. We hope that this body of work will generate new relevant discussions and inform future decisions regarding regenerative medicine."

The guest editors provide scene-setting forewords for both installments of the two-part Special Focus Issue, in which they discuss the importance of informing and engaging relevant stakeholders and how this Special Focus Issue aims to facilitate this. They subsequently provide an overview of the wide variety of work presented in each issue including original research, perspectives and commentaries.
-end-
Both forewords are free to read here:

Part I Foreword: http://bit.ly/2ggRStH

Part II Foreword: http://bit.ly/2jedV8T

Adam Price-Evans, Managing Commissioning Editor for Regenerative Medicine, commented: "While the field of regenerative medicine offers great promise for novel therapeutics, there are still issues that must be addressed to ensure safe, ethical and regulated translation of research from bench to bedside. I am delighted to announce the publication of this two-part Special Focus Issue as it offers perspectives on many key questions that must be answered for this field to flourish and ultimately improve the lives of patients around the world."

View Parts I and II of "Regenerative Medicine in Society: Interdisciplinary Perspectives" here:

Part I: https://www.futuremedicine.com/toc/rme/12/6

Part II: https://www.futuremedicine.com/toc/rme/12/7

All articles published in Part I and II of the Special Focus Issue will be freely available to members of RegMedNet throughout November-2017.

You can gain access here: https://www.future-science-group.com/joinrmn_2sfi-rme-access-2017/

About Regenerative Medicine

Regenerative Medicine is part of the internationally recognized Future Medicine portfolio and is supported by a multidisciplinary, international editorial board comprising leading researchers and opinion leaders from academia and industry, including Senior Editor Chris Mason (UCL, UK), and Associate Editors Robert Lanza (Astellas GRM, CA, USA), Phillipe Menasché (Hôpital Européen Georges Pompidou, FR), Gail Naughton (Histogen Inc., CA, USA) and Glyn Stacey (UK Stem Cell Bank, UK).

Regenerative Medicine focuses on the entire spectrum of approaches in regenerative medicine, including small molecule drugs, biologics, biomaterials, tissue engineering, and cell and gene therapies. The peer-reviewed journal uniquely supports this important area of biomedical science and healthcare by publishing the very best research and opinion, encompassing all aspects of the sector ranging from discovery research, to clinical development and commercialization.

For additional information on the journal's aims and scope, editorial board and the latest content, please visit the the Future Medicine website: https://www.futuremedicine.com/journal/rme

The journal is also partnered with RegMedNet, a free eCommunity aiming to promote global collaboration between all members of the regenerative medicine field as well as keep users up to date with the latest news and opinion, by providing exclusive features, webinars and more.

Call for papers

The journal is currently also inviting submissions of original research, reviews and perspective pieces, as well as shorter opinion pieces. Please see the "For Authors" page on the Future Medicine website or contact Adam Price-Evans, the Managing Commissioning Editor, at a.price-evans@futuremedicine.com

About Future Science Group (FSG)

Founded in 2001, London-based FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to the core journal publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, RegMedNet, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. Please see http://www.futuresciencegroup.com and http://www.futuremedicine.com for more information.

Future Science Group

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.